Skip to main content
. Author manuscript; available in PMC: 2023 May 14.
Published in final edited form as: Urology. 2018 Apr 13;128:62–65. doi: 10.1016/j.urology.2018.04.001

Table 4.

ConfirmMDx clinical performance by age range

Parameter <55 y 55–69 y ≥70 y
Total number of subjects 28 113 69
Cancer-positive (%) 11 (39%) 47 (42%) 23 (43%)
Sensitivity (95% CI) 64% (35%−85%) 70% (56%−81%) 83% (62%−94%)
Specificity (95% CI) 77% (52%−91%) 61% (49%−72%) 52% (38%−66%)